Rachel Haurwitz
Gründer bei CARIBOU BIOSCIENCES, INC.
Vermögen: 13 Mio $ am 30.04.2024
Profil
Dr. Rachel E.
Haurwitz is an Independent Director at Seer, Inc. (California) and a President, Chief Executive Officer & Director at Caribou Biosciences, Inc. She is on the Board of Directors at Seer, Inc. (California), Biotechnology Innovation Organization, BIOCOM and Caribou Biosciences, Inc. Dr. Haurwitz also served on the board at Intellia Therapeutics, Inc. She received her undergraduate degree from Harvard College and a doctorate degree from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2024 | 3 389 395 ( 3,75% ) | 13 Mio $ | 30.04.2024 | |
SEER, INC. CLASS A
0,05% | 14.06.2023 | 29 437 ( 0,05% ) | 51 515 $ | 30.04.2024 |
Aktive Positionen von Rachel Haurwitz
| Unternehmen | Position | Beginn |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Gründer | 28.10.2011 |
| SEER, INC. | Direktor/Vorstandsmitglied | 08.11.2021 |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 26.02.2019 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | 01.02.2020 |
Ehemalige bekannte Positionen von Rachel Haurwitz
| Unternehmen | Position | Ende |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Gründer | 01.11.2016 |
Ausbildung von Rachel Haurwitz
| University of California, Berkeley | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| SEER, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
